AMYT.L Share News (AMYT)
AMYT Share
AMYT Share
AMYT Share
AMYT Share
AMYT
AMYT Share
AMYT Broker
AMYT Directors
AMYT Financial
AMYT
AMYT Short
AMYT
(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma released efficacy and safety data from the 'Lochnes' investigator-sponsored study of lomitapide in familial chylomicronemia syndrome (FCS) on Tuesday, which was conducted by expert lipidologists in Italy.
Read more(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced the validation of its marketing authorisation application for 'Oleogel-S10' by the European Medicines Agency on Monday, for the potential treatment of cutaneous manifestations of junctional and dystrophic epidermolysis bullosa.
Read more
IN BRIEF: Amryt gets positive feedback on Myalept from US regulator
Read more(Sharecast News) - Commercial-stage biopharmaceuticals company Amryt Pharma has received further feedback from the United States Food and Drug Administration (FDA) on Myalept, it said on Tuesday, and its proposed development plan and study design to support an indication for patients with partial lipodystrophy (PL).
Read moreIN BRIEF: Amryt's Myalepta secures reimbursement approval in France
Read more(Sharecast News) - Commercial-stage biopharmaceuticals company Amryt Pharma announced on Monday that the French Ministry of Social Affairs and Health has approved 'Myalepta', or metreleptin, for reimbursement in the country as an adjunct to diet as replacement therapy.
Read more(Sharecast News) - Amryt Pharma revealed on Monday that chairman Ram Stafford had acquired 300,100 ordinary shares in the AIM-listed commercial-stage biopharmaceutical company.
Read moreIN BRIEF: Amryt, Medison sign distribution deal for Myalepta in Canada
Read more(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced the signing of a distribution agreement with Medison Pharma to distribute 'Myalepta' in Canada on Monday.
Read moreTRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance
Read more(Sharecast News) - Commercial-stage biopharmaceuticals company Amryt Pharma announced the signing of multi-regional distribution agreements with Medison Pharma on Thursday.
Read moreAmryt Pharma Signs Drug Distribution Agreements With Medison Pharma
Read moreIN BRIEF: Amryt Receives Reimbursement Approval For Myalepta
Read moreUK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost
Read more(Sharecast News) - Biopharmaceutical company Amryt announced on Thursday that Ministry of Health reimbursement approval has been granted for 'Lojuxta', or lomitapide, in Saudi Arabia.
Read more